BioCentury
ARTICLE | Company News

Bostwick, Sangretech deal

October 26, 2009 7:00 AM UTC

The partners added undisclosed amendments to a 2007 licensing deal that granted Bostwick's Bostwick Scientific research division rights to use Sangretech's dendritic cell technology to develop and com...